These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9704431)

  • 21. The safety of blood components and derivatives.
    Julius C; Westphal RG
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-I and blood safety: let the community decide.
    Kaldor JM
    Med J Aust; 1997 May; 166(9):454-5. PubMed ID: 9152336
    [No Abstract]   [Full Text] [Related]  

  • 23. Seroprevalence and associated risk factors for HIV, Hepatitis B and C among blood Donors in South Gondar District blood Bank, Northwest Ethiopia.
    Negash M; Ayalew M; Geremew D; Workineh M
    BMC Infect Dis; 2019 May; 19(1):430. PubMed ID: 31096921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B and blood safety.
    Kitchen A
    Vaccine; 1998 Nov; 16 Suppl():S34-7. PubMed ID: 9915031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between science, government and media on selection and testing of donors.
    Sazama K
    Vox Sang; 1998; 74 Suppl 2():503-6. PubMed ID: 9704490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contaminated blood.
    Machin SJ
    Med Leg J; 2004; 72(Pt 3):77-87. PubMed ID: 15524115
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District.
    Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG
    Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria.
    Opaleye OO; Igboama MC; Ojo JA; Odewale G
    J Immunoassay Immunochem; 2016; 37(1):29-42. PubMed ID: 25879258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J; Laperche S; ; ;
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of additional blood screening tests in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; Bonsel GJ; van Hout BA
    Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
    Ben Jemia R; Gouider E
    Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
    Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
    Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What future means to management of blood centres.
    van Aken WG
    Vox Sang; 1998; 74 Suppl 2():115-8. PubMed ID: 9704432
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of residual infectious risk among blood donors in National Center of Blood Transfusion in Conakry].
    Loua A; Sow EM; Magassouba FB; Camara M; Baldé MA
    Transfus Clin Biol; 2004 Apr; 11(2):98-100. PubMed ID: 15120107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
    Murphy EL
    Transfus Clin Biol; 2016 Feb; 23(1):13-9. PubMed ID: 26778839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
    Ouattara H; Siransy-Bogui L; Fretz C; Diane KM; Konate S; Koidio A; Minga KA; Hyda J; Koffi-Abe N; Offoumou AM; Abissey S
    Transfus Clin Biol; 2006 Oct; 13(4):242-5. PubMed ID: 16822686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.